Physician profile
Christian Head
NPI 1790700094
$607.49
in general payments reported to CMS, 2019-2025
10 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $220 · 2024: $112 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $433.25 | 2023-2025 | Nucala |
| Inspire Medical Systems, INC. | $34.93 | 2023 | Inspire |
| Optinose US, INC. | $22.70 | 2023 | |
| Medtronic, INC. | $20.46 | 2025 | Stealth Autoguide System |
| Boston Scientific Corporation | $18.62 | 2025 | Axonics |
| Tactile Systems Technology INC | $17.91 | 2025 | Nimbl, Flexitouch Plus |
| Genzyme Corporation | $15.85 | 2024 | |
| Axonics, INC. | $15.69 | 2023 | Axonics |
| Astrazeneca Pharmaceuticals LP | $15.18 | 2025 | |
| Phathom Pharmaceuticals, INC. | $12.90 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Head listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.